| #579 |
Vipul C. Chitalia |
Unknown |
1 |
| #579 |
Yin Yin Lin |
Momenta Pharmaceuticals |
1 |
| #579 |
Jacqueline M. Smith |
Actifio |
1 |
| #579 |
Anita A. Kurmann |
Beth Israel Deaconess Medical Center |
1 |
| #579 |
Bruce Smith |
Hydrow |
1 |
| #579 |
Paul Erich Keel |
Unknown |
1 |
| #579 |
David A. Scott |
Arbor Biotechnologies |
1 |
| #579 |
Parastoo Khoshakhlagh |
Harvard University |
1 |
| #579 |
Lucas Waye |
Rovi Guides |
1 |
| #579 |
Paxton Maeder-York |
Harvard University |
1 |
| #579 |
Celeste Richardson |
Novartis Ag |
1 |
| #579 |
Patrick Hsu |
Salk Institute For Biological Studies |
1 |
| #579 |
David Perry |
GE |
1 |
| #579 |
Maxim Lobovsky |
Formlabs |
1 |
| #579 |
Anthony P. Shuber |
Exact Sciences |
1 |
| #579 |
Andreas Mershin |
MIT |
1 |
| #579 |
Todd Golub |
Dana-Farber Cancer Institute |
1 |
| #579 |
Sourav Roy Choudhury |
University Of Massachusetts |
1 |
| #579 |
Justin Wolfe |
Endochoice |
1 |
| #579 |
James W. Nelson |
Radio Frequency Systems |
1 |
| #579 |
Jon Come |
Vertex Pharmaceuticals Incorporated |
1 |
| #579 |
Derek Cerchione |
Editas Medicine |
1 |
| #579 |
Don Straus |
Rapid Micro Biosystems |
1 |
| #579 |
Charles Roques-Carmes |
MIT |
1 |
| #579 |
Ross Taylor |
Takeda Vaccines |
1 |
| #579 |
Muhammad Masood |
Bose |
1 |
| #579 |
Michael Goldstein |
Intel |
1 |
| #579 |
Mordechai Perlman |
Boston Scientific Scimed |
1 |
| #579 |
Evan Schwab |
Koniniklijke Philips N.V. |
1 |
| #579 |
John P. Wise |
Lovepop |
1 |
| #579 |
Markus Frank |
Brigham and Women's Hospital |
1 |
| #579 |
Igor Gilitschenski |
MIT |
1 |
| #579 |
Jim Best |
Biogen Ma |
1 |
| #579 |
Alexander Decastro Calachan |
Bose |
1 |
| #579 |
Sivaraman Dandapani |
The Broad Institute |
1 |
| #579 |
Jan M. Schnorr |
MIT |
1 |
| #579 |
Kamal Youcef-Toumi |
MIT |
1 |
| #579 |
Peter A. Raffensperger |
Apple |
1 |
| #579 |
Michael Eilenberg |
MIT |
1 |
| #579 |
Ganeshsingh A. Thakur |
Northwestern University |
1 |
| #579 |
Satya Kuchimanchi |
Alnylam Pharmaceuticals |
1 |
| #579 |
Melissa Marie Vasbinder |
Ribon Therapeutics |
1 |
| #579 |
Mark Romanowsky |
E Ink Holdings |
1 |
| #579 |
Josh Su |
Nike |
1 |
| #579 |
Yvonne J. Yamanaka |
Kaleido Biosciences |
1 |
| #579 |
Laura Lewis |
Traulsen & Company |
1 |
| #579 |
Paul Nicholas Whatmough |
NVIDIA |
1 |
| #579 |
Pamela M. Holland |
Surface Oncology |
1 |
| #579 |
Christopher Gerard Wilson |
University of California |
1 |
| #579 |
Edward F. Gleason |
The Dow Chemical |
1 |